发明名称 IMPROVED EXTENDED RELEASE FORMULATION FOR HMG-CoA REDUCTASE INHIBITOR
摘要 <P>PROBLEM TO BE SOLVED: To provide a new controlled-release formulation slowly releasing a compound which is an alkyl ester of a hydroxy-substituted naphthalene derivative. <P>SOLUTION: The controlled-release formulation includes (a) a compressed tablet core containing lovastatin, an osmotic agent and a pharmaceutically acceptable water-swellable polymer, (b) an inner coating containing an enteric polymer selected from the group consisting of hydroxypropylmethylcellulose phthalate, cellulose acetate phthalate, polyvinyl acetate phthalate and methacrylic acid/methacrylate copolymers, and (c) an outer coating containing a mixture of a methacrylic acid/methyl methacrylate copolymer, a channeling agent and a water-insoluble cellulose polymer. The weight ratio of the methacrylic acid/methyl methacrylate copolymer to the water-insoluble cellulose polymer in the outer coating is 0.1:1-0.75:1. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2010229150(A) 申请公布日期 2010.10.14
申请号 JP20100135848 申请日期 2010.06.15
申请人 ANDRX PHARMACEUTICALS INC 发明人 CHEN CHIH-MING;CHOU JOSEPH;WONG DAVID
分类号 A61K31/366;A61K9/00;A61K9/20;A61K9/24;A61K9/28;A61K9/32;A61K9/36;A61K31/22;A61K31/351;A61K47/32;A61K47/34;A61K47/38;A61P3/06;A61P43/00 主分类号 A61K31/366
代理机构 代理人
主权项
地址